Loading
29-Jan-2013 1:22 PM

Ryanair reports double-digit profit growth in 3QFY2013, upgrades full year profit guidance

Ryanair revenue up 15% - financial highlights for three months ended 31-Dec-2012:

  • Operating revenue: EUR968.8 million, +14.7% year-on-year;
    • Ancillary: EUR220.1 million, +24.4%;
  • Total operating costs: EUR934.2 million, +14.6%;
    • Fuel: EUR414.8 million, +24.3%;
    • Airport and handling charges: EUR137.1 million, +13.2%;
    • Route charges: EUR104.8 million, +5.1%;
    • Labour: EUR99.8 million, +8.1%;
  • Operating profit: EUR34.6 million, +17.7%;
  • Profit before tax: EUR19.3 million, +24.5%;
  • Profit after tax: EUR18.1 million, +21%;
  • Passenger numbers: 17.3 million, +3%;
  • Load factor: 81%, stable;
  • Average fare: EUR43, +8%;
  • Revenue per passenger: EUR56, +11%;
  • Total assets: EUR8481 million, -5.8% when compared to period ended 31-Mar-2012;
  • Cash and cash equivalents: EUR846.7 million, -68.7% when compared to period ended 31-Mar-2012;
  • Total liabilities: EUR5252 million, -7.8% when compared to period ended 31-Mar-2012. [more - original PR]

Ryanair: "Our Q3 yields were boosted by stronger pre-Christmas bookings, while lower than expected operating costs delivered slightly better profits than forecast. However Q4 traffic (as previously guided) will drop by approximately 400,000 passengers (-3%) below last year's Q4, due to our grounding up to 80 aircraft which limits the impact of high oil prices, high airport fees at Stansted and Dublin, and seasonally weaker Q4 demand. On the basis of this improved Q3 result, our capacity cuts and limited visibility over Easter bookings and yields, (although we have seen some yield softness in January), we now expect our full year profits to exceed our previous guidance (of EUR490m to EUR520m) and rise close to EUR540m, a 7% increase on last year's profits despite a 19% increase in our oil costs." Source: Company statement, 28-Jan-2013.

Want More News Like This?

CAPA Membership provides access to all news and analysis on the site, along with access to many areas of our comprehensive databases and toolsets.
Find Out More